溶血性输血反应

  • 网络hemolytic transfusion reaction;DHTR
溶血性输血反应溶血性输血反应
  1. 结论该例同种抗体为特异性抗Mur抗体,在临床会引起溶血性输血反应。

    Conclusions This alloantibody is a specific anti-Mur antibody , and it can cause the hemolytic transfusion reaction .

  2. 非溶血性输血反应的影响因素分析

    Study on the Factors for Non - hemolytic Transfusion Reaction

  3. 非溶血性输血反应与HLA抗体

    Nonhemolytic Transfusion Reaction and Anti - HLA

  4. Rh血型系统是具有重要临床意义的血型系统,该系统的抗原不相容能引起溶血性输血反应、新生儿溶血病(HDN)和自身免疫性溶血性贫血。

    The Rh blood group system is one of the most significant red blood cell systems in transfusion medicine , incompatible Rh antigens are associated with hemolytic transfusion reactions , hemolytic disease of the newborn and autoimmune hemolytic anemia .

  5. 目的为了解我区非溶血性输血反应的发生情况。

    Objective To find out incidence of non - hemolytic transfusion reactions .

  6. 使用非那根预防非溶血性输血反应必要性分析

    Study on the necessary of using promethazine to prevent non-hemolytic transfusion reaction

  7. 血清;不规则抗体;溶血性输血反应。

    Serum ; Irregular antibody ; Hemolytic transfusion reaction .

  8. 地塞米松和异丙嗪预防非溶血性输血反应的观察

    Activities of Dexamethasone and Diprazine Against Nonhemolytic Transfusion Reaction

  9. 抗-Jk~a致溶血性输血反应结果分析

    Analysis of anti-Jk ~ a induced hemolytic transfusion reaction

  10. 目的对预输血患者进行不规则抗体的筛查,降低和避免溶血性输血反应的发生。

    Objective In order to decrease or avoid hemolytic transfusion reaction , to screen irregular antibodies .

  11. 目的探讨使用非那根预防非溶血性输血反应是否必要。

    Objective To study whether it is necessary to use promethazine to prevent non-hemolytic transfusion reaction .

  12. 对有同种抗体的患者输入相应抗原阴性的红细胞后,患者未发生溶血性输血反应;

    No hemolytic transfusion reaction occurred in patients with isoantibody after infusion of blood with corresponding antigen negative .

  13. 为探讨非溶血性输血反应的影响因素,对510例次输血进行了调查。

    In order to study the factors for non hemolytic transfusion reaction , 510 case time transfusion was investigated .

  14. 目的通过对临床申请输血患者不完全抗体的检测,以减少或杜绝溶血性输血反应的发生。

    Objective To detect irregular antibodies in serum samples of clinical patients , in order to decrease or avoid hemolytic transfusion reaction .

  15. 结论非溶血性输血反应与性别、输血次数、血成分制品及受血者过敏体质等有关。

    Conclusions The non-hemolytic transfusion reactions was related with sex ? numbers of transfusion ? blood products and the allergic constitutions of recipient .

  16. 结论:白细胞滤器能有效去除白细胞,去除白细胞能减少非溶血性输血反应。

    Conclusion Leukocyte removal filter can effectively deplete the leukocytes in blood , its application may be useful to reduce non-hemolytic blood transfusion reaction .

  17. 取过滤前后血液标本进行血液质量检测,并观察临床非溶血性输血反应发生率降低的程度。

    Samples before and after filtration were undergone blood quality detection and then observed the extent it reduced the incidence of clinical non-hemolytic transfusion reactions .

  18. 这种反应被称为溶血性输血反应,可导致血压下降、出血或者肾损伤而危及生命。

    Such a reaction , called a hemolytic transfusion reaction , can lead to a drop in blood pressure , bleeding or kidney damage which may be life-threatening .

  19. 结论:白细胞过滤器能高效地、有选择性地滤除白细胞和血小板,能显著降低临床非溶血性输血反应的发生率。

    Conclusion : The leukocyte filter can remove leukocyte and thrombocyte with high efficiency and selectivity . It also can significantly reduce the incidence of clinical non-hemolytic transfusion reactions .

  20. 结果非溶血性输血反应发生为10.20%(52/510),其中发热反应率占84.62%(44/52),过敏反应率占15.38%(8/52);

    It was found that the incidence of non hemolytic transfusion reaction was 10.20 % , fever reaction rate being 84.62 % and anaphylactoid rate 15.38 % , respectively .

  21. 目的:检查有输血史或妊娠史的患者血清(浆)中不规则抗体,以减少或杜绝溶血性输血反应的发生。

    Objective : To detect irregular antibodies in the serum samples of patients who had a history of blood transfusion or pregnancy , in order to decrease or avoid hemolytic transfusion reaction .

  22. 结论60Coγ射线照射血液制品输注在有效预防输血相关性移植物抗宿主病的同时也能有效减少非溶血性发热输血反应的发生。

    Conclusion ~ 60 Co - irradiated blood can not only prevent transfusion associated graft-versus-host disease ( TA-GVHD ), but also decrease non-hemolytic febrile transfusion reactions ( NHFTR ) effectively .

  23. 目的评价临床输注去白细胞红细胞悬液和浓缩血小板预防非溶血性发热性输血反应(FNHTR)的效果。

    Objective To assess the clinical efficiency of preventing febrile nonhemolytic transfusion reactions ( FNHTR ) with transfusion of leukocyte filtration RBC and platelet concentrates .

  24. 结论使用国产滤器能去除血液成分中99%以上的白细胞,能有效地预防非溶血性发热性输血反应。

    Conclusion Domestic filter can filtrate about 99 % leucocytes from SAGM RBCs and the filtration may effectively prevent non hemolytic febrile transfusion reactions .

  25. 结论:白细胞滤器制备的少白细胞的红细胞制品能有效地预防白细胞抗体所致的同种免疫性非溶血性发热性输血反应,有临床实用价值。

    Conclusion : The WBC filter , by filtering out the WBC in the blood , can effectively prevent the anti WBC Ab induced , non hemolytic fever reaction in blood transfusion and can be recommended for clinical use .

  26. 采用白细胞专用滤器,则可去除血液中99.9%的白细胞,可以明显减少白细胞介导的输血反应,如非溶血性发热性输血反应和移植物抗宿主病。

    Using special filters , blood component can be filtrated 99.9 % of the leucocytes . Leucocyte depletion using filter should significantly lessen the leucocyte mediated transfusion adverse reactions , such as febrile non hemolytic transfusion reactions and graft versus host disease .

  27. RhD抗原的高免疫原性常常会引起胎儿和新生儿溶血病(HDFN)、溶血性输血反应和自身免疫性溶血性贫血等疾病。

    The highly immunogenic RhD antigen is often involved in hemolytic disease of the fetal and newborn ( HDFN ), hemolytic transfusion reactions and autoimmune hemolytic anemia .